Emulate‘s small airway-lung chip could help researchers study viral-induced exacerbations of asthma, according to data presented this week at the American Thoracic Society’s annual meeting.
The studies were conducted as part of the company’s partnership with (NYSE:MRK). The collaborative project was designed to enable development of new anti-inflammatory treatments for patients with asthma, according to Emulate.
Get the full story at our sister site, Drug Delivery Business News.
The post ATS Roundup: Emulate models viral infection in “asthma-on-a-chip” appeared first on MassDevice.